Literature DB >> 19117377

PEGylated and MMP-2 specifically dePEGylated quantum dots: comparative evaluation of cellular uptake.

Hyejung Mok1, Ki Hyun Bae, Cheol-Hee Ahn, Tae Gwan Park.   

Abstract

Polyethylene glycol (PEG)-immobilized quantum dot (QD) nanoparticles, which could be specifically dePEGylated in response to the presence of the matrix metalloprotease-2 (MMP-2) enzyme, were prepared. The degree of PEGylation (MW 3400) on the surface of 12 nm streptavidin-coated QDs was stoichiometrically controlled by varying the feed amount of a biotin-substrate-PEG conjugate, where the substrate contained an MMP-2 cleavable peptide sequence. A biotin-cell penetrating peptide (CPP) conjugate was also immobilized onto the surface of the PEGylated QD surface to enhance the cellular uptake after dePEGylation. It was found that more than nine PEG chains per single QD were required to effectively inhibit the cellular uptake of modified QD particles down to around 20%, as compared with that of QD without PEG chains. However, the treatment of MMP-2 enzyme in the medium resulted in a substantial enhancement in the extent of QD cellular uptake by dePEGylation with concomitant resurfacing of sterically hidden CPP moieties. This study analyzed the effects of surface PEGylation density and MMP-2 specific dePEGylation on the cellular uptake of CPP-QD nanoparticles in a quantitative manner.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19117377     DOI: 10.1021/la803542v

Source DB:  PubMed          Journal:  Langmuir        ISSN: 0743-7463            Impact factor:   3.882


  22 in total

Review 1.  Quantum dot-based theranostics.

Authors:  Yi-Ping Ho; Kam W Leong
Journal:  Nanoscale       Date:  2009-10-06       Impact factor: 7.790

2.  Investigating the Cellular Specificity in Tumors of a Surface-Converting Nanoparticle by Multimodal Imaging.

Authors:  Francois Fay; Line Hansen; Stefanie J C G Hectors; Brenda L Sanchez-Gaytan; Yiming Zhao; Jun Tang; Jazz Munitz; Amr Alaarg; Mounia S Braza; Anita Gianella; Stuart A Aaronson; Thomas Reiner; Jørgen Kjems; Robert Langer; Freek J M Hoeben; Henk M Janssen; Claudia Calcagno; Gustav J Strijkers; Zahi A Fayad; Carlos Pérez-Medina; Willem J M Mulder
Journal:  Bioconjug Chem       Date:  2017-05-05       Impact factor: 4.774

3.  Digital switching of local arginine density in a genetically encoded self-assembled polypeptide nanoparticle controls cellular uptake.

Authors:  Sarah R Macewan; Ashutosh Chilkoti
Journal:  Nano Lett       Date:  2012-05-31       Impact factor: 11.189

4.  Tumor targeting of a cell penetrating peptide by fusing with a pH-sensitive histidine-glutamate co-oligopeptide.

Authors:  Likun Fei; Li-Peng Yap; Peter S Conti; Wei-Chiang Shen; Jennica L Zaro
Journal:  Biomaterials       Date:  2014-02-06       Impact factor: 12.479

Review 5.  Chemical basis of interactions between engineered nanoparticles and biological systems.

Authors:  Qingxin Mu; Guibin Jiang; Lingxin Chen; Hongyu Zhou; Denis Fourches; Alexander Tropsha; Bing Yan
Journal:  Chem Rev       Date:  2014-06-13       Impact factor: 60.622

6.  Facile synthetic route for surface-functionalized magnetic nanoparticles: cell labeling and magnetic resonance imaging studies.

Authors:  Hyun Jung Chung; Haeshin Lee; Ki Hyun Bae; Yuhan Lee; Jongnam Park; Seung-Woo Cho; Jin Young Hwang; Hyunwook Park; Robert Langer; Daniel Anderson; Tae Gwan Park
Journal:  ACS Nano       Date:  2011-06-06       Impact factor: 15.881

Review 7.  Cell-penetrating peptide-functionalized quantum dots for intracellular delivery.

Authors:  Betty R Liu; Yue-Wern Huang; Huey-Jenn Chiang; Han-Jung Lee
Journal:  J Nanosci Nanotechnol       Date:  2010-12

Review 8.  Harnessing the power of cell-penetrating peptides: activatable carriers for targeting systemic delivery of cancer therapeutics and imaging agents.

Authors:  Sarah R MacEwan; Ashutosh Chilkoti
Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol       Date:  2012-09-13

Review 9.  Nanomaterials for cancer therapy and imaging.

Authors:  Ki Hyun Bae; Hyun Jung Chung; Tae Gwan Park
Journal:  Mol Cells       Date:  2011-02-25       Impact factor: 5.034

10.  Polydopamine-based surface modification for the development of peritumorally activatable nanoparticles.

Authors:  Emily Gullotti; Joonyoung Park; Yoon Yeo
Journal:  Pharm Res       Date:  2013-04-23       Impact factor: 4.200

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.